Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C.
Thrombosis and Haemostasis 81(4): 659-660
1999
ISSN/ISBN: 0340-6245 PMID: 10235458 Document Number: 510169
Document emailed within 1 workday
Related Documents
Strobel, J.; Ringwald, J.; Zimmermann, R.; Eckstein, R. 2010: Thromboembolic Risk Assessment in a Phenotypically Cured Factor-V-Leiden Carrier after Orthotopic Liver Tr ansplantation Clinical Laboratory 56(5-6): 245-247Batlle, J.; López Fernández, M.F. 1999: The importance of studying factor V Leiden and the 20210 [correction of 29210A] allele of the prothrombin gene in thromboembolic disease Sangre 44(1): 3-6
Bertina, R.M. 1997: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk Clinical Chemistry 43(9): 1678-1683
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Hummel, L. 1993: Importance of the fibrinogen concentration as an independent risk factor for ischemic heart disease Wiener Medizinische Wochenschrift 143(18): 469-472
Aksoy, M.; Tek, I.; Karabulut, H.; Berker, B.; Soylemez, F. 2005: The role of thrombofilia related to Factor V Leiden and Factor II G20210A mutations in recurrent abortions Jpma. Journal of the Pakistan Medical Association 55(3): 104-108
Ferrara, E.; Cucchi, G.; Sardeo, C. 1989: Fibrinogen, a cardiovascular risk factor Minerva Cardioangiologica 37(11): 473-475
Giannasi, G.; Ferrari, S.; Galetta, F. 1995: Fibrinogen as a cardiovascular risk factor Minerva Cardioangiologica 43(5): 169-175
El-Diasty, A.M.; Shahin, M. 2008: Anticardiolipin antibodies in diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy Egyptian Journal of Immunology 15(1): 101-107
Lecumberri, Rón.; Ceberio, I.; Montes, Rón.; López, Mía.Luz.; Alberca, I.; Rocha, E. 2003: Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease Haematologica 88(2): 236-237
Cardoso, M.R.A.; Cousens, S.N.; de Góes Siqueira, L.F.; Alves, F.át.M.; D'Angelo, L.A.ôn.V. 2004: Crowding: risk factor or protective factor for lower respiratory disease in young children? Bmc Public Health 4: 19
Egbring, R.; Schmidt, W.; Havemann, K. 1973: Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1351-1354
2001: Summaries for patients. Blood clots in people with the factor V Leiden mutation Annals of Internal Medicine 135(5): S-34
Jastrzebska, M.; Przybycień, K.; Chelstowski, K.; Torbus-Lisiecka, B.; Kornacewicz-Jach, Z.; Naruszewicz, M. 1999: Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography Nutrition Metabolism and Cardiovascular Diseases: Nmcd 9(1): 33-40
Verheggen, P.W.; Heymans, B.T.; Slagboom, P.E.; Haverkate, F.; Cats, V.M. 1997: Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina Thrombosis and Haemostasis 77(6): 1218
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Kharchenko, T.V.; Arzhavkina, L.G.; Sinyachkin, D.A.; Yazenok, A.V.; Kryuchkova, A.S. 2014: Smoking as an additional risk factor for the staff of chemically hazardous production facilities Gigiena i Sanitariia 1: 77-80
Coughlin, P.A.; Gulati, V.; Mavor, A.I.D.; Gough, M.J.; Homer-Vanniasinkam, S. 2007: Risk factor awareness in patients with peripheral arterial disease Journal of Cardiovascular Surgery 48(6): 735-740
Tani, M.; Bossini, S.; Maffetti, G. 1991: Fibrinogen and factor VIi levels in patients under estrogen-progestin therapy Minerva Ginecologica 43(11): 519-524
Ozbek, U.; Tangün, Y. 1996: Frequency of factor V Leiden in Turkey International Journal of Hematology 64(3-4): 291-292